Bioretec
2.41
EUR
+1.26 %
1,520 following
BRETEC
First North Finland
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Income statement
Valuation
Quarterly estimates
Income statement
2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025e | 2026e | 2027e | 2028e | |
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1.6 | 1.7 | 1.5 | 2.0 | 2.9 | 3.9 | 4.5 | 6.8 | 10.1 | 16.7 | 23.4 |
growth-% | 10.2 % | -14.2 % | 33.6 % | 46.9 % | 32.8 % | 16.3 % | 49.1 % | 49.4 % | 64.6 % | 40.4 % | |
EBITDA | -1.6 | -1.6 | -2.1 | -2.8 | -2.0 | -2.8 | -4.1 | -3.8 | -1.8 | 0.2 | 4.1 |
EBIT (adj.) | -1.6 | -1.7 | -1.9 | -2.7 | -2.3 | -3.0 | -4.2 | -4.0 | -2.5 | -0.5 | 3.5 |
EBIT | -1.6 | -1.7 | -1.9 | -2.7 | -2.3 | -3.0 | -4.2 | -4.0 | -2.5 | -0.5 | 3.5 |
Profit before taxes | -2.1 | -1.7 | -2.3 | -6.0 | -2.4 | -3.8 | -4.6 | -4.7 | -2.6 | -0.6 | 3.4 |
Net income | -2.1 | -1.7 | -2.3 | -6.0 | -2.4 | -3.8 | -4.6 | -4.7 | -2.6 | -0.6 | 3.4 |
EPS (adj.) | -0.02 | -0.01 | -0.02 | -0.43 | -0.17 | -0.20 | -0.20 | -0.20 | -0.11 | -0.03 | 0.14 |
growth-% | |||||||||||
Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Dividend ratio |
Profitability and return on capital
2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025e | 2026e | 2027e | 2028e | |
---|---|---|---|---|---|---|---|---|---|---|---|
EBITDA-% | -98.8 % | -91.9 % | -137.8 % | -141.6 % | -68.0 % | -72.6 % | -89.2 % | -56.3 % | -17.3 % | 1.1 % | 17.6 % |
EBIT-% (adj.) | -101.1 % | -99.4 % | -128.4 % | -133.1 % | -77.9 % | -77.7 % | -92.5 % | -59.4 % | -24.7 % | -2.9 % | 15.0 % |
EBIT-% | -101.1 % | -99.4 % | -128.4 % | -133.1 % | -77.9 % | -77.7 % | -92.5 % | -59.4 % | -24.7 % | -2.9 % | 15.0 % |
ROE | 282.3 % | -4,642.9 % | -211.2 % | -77.8 % | -74.7 % | -51.2 % | -63.1 % | -69.2 % | -29.6 % | 95.9 % | |
ROI | -115.5 % | -90.4 % | -54.8 % | -46.8 % | -42.9 % | -38.4 % | -47.4 % | -47.6 % | -9.1 % | 54.6 % |